UCB SA (UCBJF)
250.59
-1.50
(-0.60%)
USD |
OTCM |
Sep 15, 16:00
UCB Price : 250.59 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 250.59 | 250.59 | 250.59 | 250.59 | 237.00 |
| Sep 14, 2026 | 242.25 | 252.09 | 242.25 | 252.09 | 54.00 |
| Sep 11, 2026 | 250.43 | 250.43 | 246.15 | 246.15 | 272.00 |
| Sep 10, 2026 | 235.10 | 245.56 | 231.00 | 231.75 | 252.00 |
| Sep 09, 2026 | 246.44 | 246.44 | 246.44 | 246.44 | 52.00 |
| Sep 08, 2026 | 251.34 | 251.34 | 246.78 | 251.34 | 279.00 |
| Sep 04, 2026 | 248.40 | 255.34 | 241.56 | 255.34 | 72.00 |
| Sep 03, 2026 | 268.09 | 268.09 | 248.60 | 248.60 | 69.00 |
| Sep 02, 2026 | 264.09 | 264.09 | 244.50 | 264.09 | 389.00 |
| Sep 01, 2026 | 258.46 | 264.74 | 252.16 | 252.16 | 84.00 |
| Aug 31, 2026 | 250.88 | 250.88 | 250.88 | 250.88 | 0.000 |
| Aug 28, 2026 | 250.83 | 250.88 | 250.83 | 250.88 | 16.00 |
| Aug 27, 2026 | 267.75 | 267.75 | 267.59 | 267.59 | 100.00 |
| Aug 26, 2026 | 266.59 | 266.59 | 266.59 | 266.59 | 42.00 |
| Aug 25, 2026 | 267.34 | 267.34 | 267.34 | 267.34 | 0.000 |
| Aug 24, 2026 | 267.34 | 267.34 | 267.34 | 267.34 | 10.00 |
| Aug 21, 2026 | 263.09 | 263.09 | 263.09 | 263.09 | 1.000 |
| Aug 20, 2026 | 263.84 | 263.84 | 259.10 | 259.10 | 113.00 |
| Aug 19, 2026 | 247.36 | 261.34 | 247.36 | 261.34 | 80.00 |
| Aug 18, 2026 | 254.59 | 254.59 | 254.59 | 254.59 | 19222.00 |
| Aug 17, 2026 | 254.59 | 254.59 | 254.59 | 254.59 | 0.000 |
| Aug 14, 2026 | 254.59 | 254.59 | 254.59 | 254.59 | 106.00 |
| Aug 13, 2026 | 263.09 | 263.09 | 263.09 | 263.09 | 16.00 |
| Aug 12, 2026 | 261.34 | 261.34 | 261.34 | 261.34 | 25.00 |
| Aug 11, 2026 | 267.84 | 267.84 | 264.38 | 264.38 | 249.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 267.20 |
| Eli Lilly & Co. | 1136.11 |
| Novo Nordisk A/S | 42.53 |
| Pfizer Inc. | 27.55 |
| Teva Pharmaceutical Industries Ltd. | 39.25 |
Price Related Metrics
| PE Ratio | 19.00 |
| PS Ratio | 4.891 |
| PEG Ratio | 0.0212 |
| Price to Free Cash Flow | 34.55 |
| Earnings Yield | 5.26% |
| Market Cap | 47.78B |
| PEGY Ratio | 0.0212 |
| Operating PE Ratio | 15.37 |
| Normalized PE Ratio | 18.84 |